Using Spearman's rank correlation analysis, we explored the existence of a correlation between anti‐FIRΔexon2, anti‐CFAP70, anti‐KARS, anti‐SNX15, or anti‐SOHLH1 Abs and clinically used tumor markers. Here, SOHLH1 is linked to neoplasm.